Marex Group’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-3,131
Closed -$308K 650
2024
Q2
$308K Buy
+3,131
New +$319K 0.01% 407
2024
Q1
Sell
-87,500
Closed -$8.82M 539
2023
Q4
$8.82M Buy
+87,500
New +$8.68M 0.35% 60
2023
Q1
Sell
-100,000
Closed -$7.77M 270
2022
Q4
$7.77M Buy
+100,000
New +$7.6M 1.1% 18

Other funds holding CAH

Marex Group's CAH Position: Q3 2024 in Review

Marex Group sold out of Cardinal Health (CAH) in Q3 2024, closing a stake of 3,131 shares — an estimated $308K sold.

Marex Group first reported a position in CAH in Q4 2022 and held it in 3 quarters. The position peaked at $8.82M in Q4 2023. 1,015 funds tracked by Wall St. Rank hold CAH as of Q3 2024.

  • Marex Group reported no remaining Cardinal Health position as of Q3 2024 after selling out during the quarter.
  • Marex Group sold 3,131 Cardinal Health shares in Q3 2024, an estimated $308K.
  • Marex Group first reported a position in Cardinal Health in Q4 2022 and held it in 3 quarters.
  • Marex Group's Cardinal Health position peaked at $8.82M in Q4 2023.
  • 1,015 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2024.

Based on Marex Group's 13F filing for Q3 2024, filed 7 Apr 2026.